The fish that moves Oceana

Oceana, the company behind Lucky Star, is really three businesses on one balance sheet: a defensive canned-fish brand, a US-dollar fish-oil producer in Louisiana called Daybrook, and a quota-backed wild-caught division. In late 2025 the market sold the whole group down to R49 on a single bad year, one driven almost entirely by Daybrook coming off a freak fish-oil high while the brand at the centre held firm. It was a mistake, and the share has since round-tripped back to R68.42.

On through-cycle earnings the business is worth about R62, in a fair-value range of roughly the low sixties to low seventies. So the opportunity that existed at R49 has closed. From here the call is narrow and specific: the upside is a bet that Daybrook's fish-oil economics re-accelerate, and the downside is a real, structural decline in South Africa's local fish resource. A good business with a genuine moat, fairly priced after a sharp recovery, and better bought on the next dip than chased today. Our rating is Hold.

The share price tells you most of the story before we open a single statement. In February 2025 the stock traded around R67. By the end of October it had fallen to R49, a level it reached on the day the company reported a poor year and cut its dividend by 42%. It has since climbed the whole way back, and at R68.42 it now sits almost exactly where it began. An eighteen-month round trip, ending back at the start.

The question this report answers is simple. Was the fall a gift, and is there anything left now that it has been retraced? Our answer is that the fall was a gift, and most of the gift has been collected. At R49 the market was pricing Oceana as though its problems were permanent. They were not. The collapse in earnings was almost entirely one division, Daybrook, coming off an extraordinary fish-oil price spike that was never going to repeat, while Lucky Star kept doing exactly what a defensive brand is supposed to do. So the buyer at R49 bought a rand of value for roughly seventy cents. The buyer at R68.42 is paying close to full price.

It was a clear opportunity three months ago. Today it is a watch-list name with a known worth.

That leaves a narrower, more honest call than "cheap" or "expensive". At the current price Oceana is roughly fairly valued, and from here the upside is specific rather than general. It rests almost entirely on whether Daybrook's fish-oil economics re-accelerate toward the levels that structural aquaculture demand can support. The downside is equally specific: whether the collapse in South Africa's local pelagic resource, which we argue is a genuine regime shift rather than a bad year, keeps eating into the local operations. Neither is a reason to chase the share here. Both are reasons to know exactly what you would pay.

The mistake the market made in 2025 was treating Oceana as a single thing. It is not. It is three quite different businesses that happen to share a balance sheet, and they were never all going to have a bad year at the same time. The group earnings fell because one of the three came off an extraordinary high. The other two were fine.

Lucky Star, the ballast

Lucky Star is the dominant canned pilchard brand in South Africa, and canned pilchard is close to the definition of defensive demand. It is cheap protein, it does not spoil, and when household budgets tighten people buy more of it, not less. Through five years that included a pandemic, chronic load-shedding and a raw-material cost base that is now more than 80% imported, Lucky Star's operating profit sat in a band between roughly R430m and R500m every single year. It did not spike and it did not break. In the year the group as a whole fell apart, Lucky Star grew.

Daybrook, the swing

Daybrook is a Louisiana operation that catches menhaden, a small oily fish, and reduces it into fishmeal, which goes into animal feed, and fish oil, which goes into aquaculture feed, omega-3 supplements and premium pet food. It processes close to half the entire US Gulf menhaden catch, and crucially it earns in US dollars, a built-in hedge for a company whose brand and costs are in rand. The whole of Oceana's earnings cycle runs through one line in this division: the fish-oil price. In its record 2024 year Daybrook produced more than 70% of the group's operating profit on the back of a fish-oil price that had roughly doubled. In 2025 that unwound. The fish-oil price fell by nearly half, Daybrook's profit more than halved, and the group's earnings followed it down. Fishmeal, by contrast, barely moved. Fishmeal is the ballast; fish oil is the swing.

What makes this more than a commodity story is the structure of fish-oil demand, and it is the crux of the valuation. Supply is fixed by biology and quota, and it is not growing. Demand has three structural legs, all growing: salmon and other aquaculture, which already takes more than half the world's fish oil; human omega-3 consumption; and premium pet food. Fixed supply meeting rising, price-insensitive demand is why the fish-oil price has ratcheted up over the past decade rather than cycling around a flat average. On top of that structural climb sits a violent weather cycle, driven by El Niño and the Peruvian anchovy, which produces the spikes and collapses. So Daybrook's normal is not its 2020 self and it is not its 2024 peak. It is a higher floor than history suggests, with sharp swings around it. That single judgement is the most important number in this report.

One elegant feature falls out of all this. The same El Niño event that sends Daybrook's fish-oil profits up is the event that pushes the price of the imported fish Lucky Star has to buy. The two engines lean against each other. Oceana is, quietly, partly hedged against itself.

Wild Caught, the quiet recovery

The third engine lands hake, horse mackerel, squid and lobster under government quota. For a few years it was the problem child, and in 2024 it lost money. Then in 2025 it swung to a R222m profit, and the first half of 2026 came in stronger still. Cod, the world's default whitefish, has seen its quotas cut hard, and Cape hake has stepped into the gap as the preferred substitute in European markets, lifting both volume and price. Sea Harvest, Oceana's listed peer, reported exactly the same hake story independently, which tells us it is real. The discipline is not to extrapolate: the 2026 quota was trimmed 5% and the rand has firmed, so we normalise this engine near its 2025 level.

What actually protects Oceana from competition is not the Lucky Star brand and it is not the factories. It is a piece of paper issued by the state. You cannot enter South African fishing by building a plant or outspending the incumbent on marketing; you need a fishing right, the government grants them sparingly, and without one you do not have a business. Oceana holds fifteen-year rights across hake, small pelagics, horse mackerel, squid and lobster, most renewed in 2021–22 and running to 2037. When the state reshuffled the deck, the incumbent kept its hand. Offshore, Daybrook's grip on close to half the US Gulf menhaden catch is a second barrier a new entrant cannot simply buy into. Two moats, one granted in Pretoria and one earned in Louisiana.

Here is the crack, and it is a large one, though it sits under only one part of the business. A quota protects your access to a resource. It does nothing to protect the resource itself. And along South Africa's West Coast, the resource has been disappearing. The country's anchovy catch limit, the fish that feeds Oceana's local fishmeal and fish-oil plants, has fallen from around 354,000 tonnes in 2016 to roughly 35,000 tonnes in 2025. That is not a dip; it is a collapse of about ninety per cent. The science says it is not a cycle either. An ecosystem regime shift in the southern Benguela around the turn of the century moved the sardine and anchovy east, past Cape Agulhas, and it has stayed there for two decades. By the early 2020s more than sixty per cent of the national small-pelagic catch was taken off the South Coast, and Oceana's canneries and fishmeal plants are on the West Coast. The fish left the neighbourhood the infrastructure was built to serve.

A licence to catch a fish that has moved 400 kilometres down the coast is worth far less than it looks.

So the moat's value has split in two. Where the resource is healthy, it is worth every bit of its reputation: Cape hake, in a genuine up-cycle, and Gulf menhaden, a large and stable biomass an ocean away. Where the resource has gone, it protects access to fish that are no longer there. When we value the company we lean hard on this distinction: we credit the hake and menhaden rights, and we give the local small-pelagic operations almost nothing, modelling Lucky Star as a permanent importer. That is not pessimism. It is valuing the rights that still have fish behind them, and declining to pay for the ones that do not.

Between 2014 and 2016 a long line of South African companies went shopping offshore. The rand was weak, the local economy was stalling, and boards wanted hard-currency earnings and a growth story that did not depend on Johannesburg. Most of them destroyed a great deal of money: a department-store chain in Australia, a fashion retailer in Britain, a burger brand in London, a chemical plant on the US Gulf. In the same window, this fishing company from Cape Town quietly bought a menhaden processor in Louisiana, and a decade later it is one of the very few offshore acquisitions of that era a shareholder would happily do again.

Oceana paid US$382m, about R4.6bn, for Daybrook in 2015, funded with a rights issue and US-dollar debt. Since then the business has produced roughly R5.7 billion of cumulative operating profit. It has already thrown off more in operating profit than Oceana paid for it, inside ten years, and Oceana still owns it. The goodwill has never been materially written down. Set that against what everyone else did.

Four things separate Daybrook from that graveyard. It bought a resource position rather than a brand fighting for shelf space; it understood the business, because a fishing company buying a fishing asset is applying logic it already runs at home; it funded the deal in US dollars, matched to Daybrook's dollar cash flows; and it did not obviously overpay, at roughly seven times the first full year's profit. Three honest footnotes belong here, though. The goodwill absorbed most of the operating quality, so the return on the all-in capital is close to the cost of capital: it created strategic value, but it was not a bargain. Part of the success was simply the fish-oil cycle. And there is a governance asterisk over the crown jewel, which the next section takes up.

The controlling shareholder became a seller

For thirty years the anchor of Oceana's register was Brimstone, the empowerment holding company that made Oceana its very first investment in 1995 and held about a quarter of the company into 2025. In December 2025 it cut its stake from roughly 25% to 16%, for a neat and slightly uncomfortable reason. Brimstone is a holding company funded with debt, serviced by the dividends it receives from Oceana and Sea Harvest. When Oceana cut its own dividend by 42%, the cash flowing up to Brimstone fell with it, its debt cover tightened to barely more than one times, and it was forced to raise cash by selling Oceana. There is a certain irony in a company's weakness compelling its founding shareholder to sell the shares.

How it sold changes the reading entirely. This was not a holder dribbling stock onto the market and grinding the price down; it was a single negotiated block of about 9% of the company, placed with one buyer at around R53. A block placement puts far less pressure on a price than open-market selling, which means the slide to R49 was mostly the earnings cycle, with the Brimstone sale a clean one-off rather than a persistent overhang. And that overhang is now largely spent: Brimstone has more than halved its holding-company debt and made no further sales since. At 16% it is no longer a controlling shareholder at all; the register is more balanced, sitting alongside Allan Gray and the Public Investment Corporation.

The block went to Marine Edge Capital, a black-owned consortium of fishing-industry operators. That matters twice over: informed industry buyers stepped in near the low, and the stake passed from one empowerment vehicle to another, keeping intact the transformation credentials that protect a South African fishing company's rights at renewal. A forced sale that leaves the buyer as well aligned as the seller is close to a best case.

The scar

Daybrook does not catch its own fish. They come from an affiliated operator, Westbank, under a thirty-year exclusive supply agreement, of which Oceana owns only a quarter because US law requires the vessels be majority American-owned. What is not ordinary is who owns the rest: when the previous owner sold in 2016 and no qualifying buyer emerged, the company's then chief executive, an American citizen, resigned and bought the stake himself. In 2021 a whistle-blower raised concerns about how the relationship was accounted for; the company delayed results, ran an external investigation, suspended its chief financial officer and changed auditors after a relationship since 1942. No fraud was found and earnings were unaffected, but the accounting needed fixing and the underlying structure, a crown-jewel asset dependent for its fish on an entity controlled by a former executive, is permanent. It is the one genuine governance flaw in an otherwise clean business.

Pay, and the insiders

On the routine measures Oceana comes out well. The annual bonus is driven mostly by headline earnings and returns on capital, not revenue or volume, which is exactly what you want in a cyclical business, and the proof is in the down year: when earnings fell, bonuses fell with them. The one question worth putting to management is whether the return hurdle that triggers on-target pay sits a little below the cost of capital. And a small but genuine signal: in June 2026 both the chief executive and the chief financial officer bought shares on the open market with their own money, and the board extended the chief executive's contract to the end of 2027. They were buying into a recovery rather than calling the bottom, so weight it accordingly, but the people who know the business best were adding, not trimming.

Oceana cannot sensibly be valued on a single multiple, because it is not a single business. Putting one number on a defensive canned-food brand, a US-dollar commodity producer and a quota-backed trawling operation would average away the very differences that matter. So we value each engine on its own terms and add them up, taking each division at a normalised level of profit that strips out both the freak 2024 high and the depressed 2025 low, and applying a multiple drawn from the closest listed comparison.

That build produces a base fair value of about R62 a share. Two judgements move it more than any others: where Daybrook's fish-oil economics settle through the cycle, and whether Lucky Star deserves parity with AVI rather than a discount. The honest output is therefore a range, from a bear case near R47 where Daybrook stays at its trough and the pelagic decline grinds on, to a bull case near R80 where the fish-oil price re-rates toward the level that structural aquaculture demand can support. The spread is almost entirely the fish-oil price. That is not a flaw in the analysis; it is an accurate description of the business.

The verdict

At R49 in late 2025 the market was pricing Oceana as though its problems were permanent, and the buyer there paid roughly seventy cents for a rand of through-cycle value. That opportunity has closed. At R68.42 the share is fairly valued, sitting toward the upper end of a fair-value range that runs from the low sixties to the mid seventies. From here, the reward is not general re-rating but a specific bet that Daybrook's fish oil re-accelerates, and the risk is the specific one that South Africa's local pelagic resource keeps eroding. A good business with a defensive core and a genuine, government-granted moat, whose cheapness was real a few months ago and has since been corrected. For the patient investor it is a watch-list name with a known worth, better bought on the next cyclical dip than chased today.